Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing endoscop ...
Mass General Brigham and MIT created FIREFLI, a swallowable capsule inspired by fireflies that lights up to detect intestinal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback